TCM
CEROW

Tenor Capital Management’s CERo Therapeutics Warrants CEROW Stock Holding History

Tenor Capital Management’s Portfolio CEROW Stock Details CEROW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-50,000
Closed -$665 – 452
2025
Q3 		$665 Hold
50,000
– – ﹤0.01% 395
2025
Q2 		$1.19K Hold
50,000
– – ﹤0.01% 354
2025
Q1 		$725 Hold
50,000
– – ﹤0.01% 297
2024
Q4 		$415 Hold
50,000
– – ﹤0.01% 288
2024
Q3 		$255 Hold
50,000
– – ﹤0.01% 291
2024
Q2 		$1K Hold
50,000
– – ﹤0.01% 298
2024
Q1 		$3.41K Hold
50,000
– – ﹤0.01% 307
2023
Q4 		$1.18K Hold
50,000
– – ﹤0.01% 329
2023
Q3 		$3.58K Hold
50,000
– – ﹤0.01% 314
2023
Q2 		$3.06K Hold
50,000
– – ﹤0.01% 358
2023
Q1 		$2K Hold
50,000
– – ﹤0.01% 480
2022
Q4 		$2.15K Hold
50,000
– – ﹤0.01% 555
2022
Q3 		$4K Hold
50,000
– – ﹤0.01% 694
2022
Q2 		$5K Hold
50,000
– – ﹤0.01% 781
2022
Q1 		$11K Hold
50,000
– – ﹤0.01% 827
2021
Q4 		$21K Buy
+50,000
New +$23.1K ﹤0.01% 770

Other funds holding CEROW

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Tenor Capital Management's CEROW Position: Q4 2025 in Review

Tenor Capital Management sold out of CERo Therapeutics Warrants (CEROW) in Q4 2025, closing a stake of 50,000 shares — an estimated $665 sold.

Tenor Capital Management first reported a position in CEROW in Q4 2021 and held it in 16 quarters. The position peaked at $21K in Q4 2021. 1 fund tracked by Wall St. Rank holds CEROW as of Q4 2025.

  • Tenor Capital Management reported no remaining CERo Therapeutics Warrants position as of Q4 2025 after selling out during the quarter.
  • Tenor Capital Management sold 50,000 CERo Therapeutics Warrants shares in Q4 2025, an estimated $665.
  • Tenor Capital Management first reported a position in CERo Therapeutics Warrants in Q4 2021 and held it in 16 quarters.
  • Tenor Capital Management's CERo Therapeutics Warrants position peaked at $21K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held CERo Therapeutics Warrants as of Q4 2025.

Based on Tenor Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.